0.3150
+0.0050
+(1.61%)
At close: January 10 at 3:42:48 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | -- |
| Avg. Estimate | -0.35 | 0 | -1.79 | 0 |
| Low Estimate | -0.35 | 0 | -1.79 | 0 |
| High Estimate | -0.35 | 0 | -1.79 | 0 |
| Year Ago EPS | -1.44 | -0.73 | -7.58 | -1.79 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | -- | 0.00% | -- |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -1.78 | -0.82 | -0.58 | -0.64 |
| EPS Actual | -1.44 | -0.73 | -0.43 | -0.37 |
| Difference | 0.34 | 0.09 | 0.15 | 0.27 |
| Surprise % | 19.10% | 10.98% | 25.86% | 42.19% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.35 | 0 | -1.79 | 0 |
| 7 Days Ago | -0.35 | 0 | -1.79 | 0 |
| 30 Days Ago | -0.35 | 0 | -1.79 | 0 |
| 60 Days Ago | -0.69 | 0 | -2.62 | 0 |
| 90 Days Ago | -0.69 | 0 | -2.62 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | 1 |
| Up Last 30 Days | 1 | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| APS.TO | 75.69% | -- | 76.39% | -- |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/3/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/20/2024 |
Related Tickers
BCT.TO BriaCell Therapeutics Corp.
0.5900
-3.28%
HBP.TO Helix BioPharma Corp.
0.8900
-4.30%
MDNA.TO Medicenna Therapeutics Corp.
1.3700
-5.52%
ONC.TO Oncolytics Biotech Inc.
1.2500
-3.85%
CSCI.TO COSCIENS Biopharma Inc.
5.0000
+2.25%
KNBIF Kane Biotech Inc.
0.0770
0.00%
MSCL.TO Satellos Bioscience Inc.
0.8500
+1.19%
KNE.V Kane Biotech Inc.
0.1100
0.00%
MBX.TO Microbix Biosystems Inc.
0.4200
+1.20%
ATBPF Antibe Therapeutics Inc.
0.2156
-0.19%